APA

Kivlighn S. D., Zingaro G. J., Gabel R. A., Broten T. P., Schorn T. W., Schaffer L. W., Naylor E. M., Chakravarty P. K., Patchett A. A. & Greenlee W. J. (19950608). In vivo pharmacology of a novel AT1 selective angiotensin II receptor antagonist, MK-996. : American journal of hypertension.

Chicago

Kivlighn S D, Zingaro G J, Gabel R A, Broten T P, Schorn T W, Schaffer L W, Naylor E M, Chakravarty P K, Patchett A A and Greenlee W J. 19950608. In vivo pharmacology of a novel AT1 selective angiotensin II receptor antagonist, MK-996. : American journal of hypertension.

Harvard

Kivlighn S. D., Zingaro G. J., Gabel R. A., Broten T. P., Schorn T. W., Schaffer L. W., Naylor E. M., Chakravarty P. K., Patchett A. A. and Greenlee W. J. (19950608). In vivo pharmacology of a novel AT1 selective angiotensin II receptor antagonist, MK-996. : American journal of hypertension.

MLA

Kivlighn S D, Zingaro G J, Gabel R A, Broten T P, Schorn T W, Schaffer L W, Naylor E M, Chakravarty P K, Patchett A A and Greenlee W J. In vivo pharmacology of a novel AT1 selective angiotensin II receptor antagonist, MK-996. : American journal of hypertension. 19950608.